Cargando…
Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
Cisplatin is one of the chemotherapeutic drugs used for the management of oral carcinoma, in which combined therapies are estimated to exert superior therapeutic efficacy compared with monotherapy. It is known that poly(ADP-ribosyl)ation is implicated in a multiplicity of cellular activities, such a...
Autores principales: | Paterniti, Irene, Scuderi, Sarah Adriana, Casili, Giovanna, Lanza, Marika, Mare, Marzia, Giuffrida, Raffella, Colarossi, Cristina, Portelli, Marco, Cuzzocrea, Salvatore, Esposito, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301366/ https://www.ncbi.nlm.nih.gov/pubmed/34356835 http://dx.doi.org/10.3390/biomedicines9070771 |
Ejemplares similares
-
Immunomodulatory Effect of Microglia-Released Cytokines in Gliomas
por: Lanza, Marika, et al.
Publicado: (2021) -
Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
por: Barazzuol, Lara, et al.
Publicado: (2013) -
Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888
por: Tuli, Richard, et al.
Publicado: (2014) -
Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells
por: Ji, Jiuping, et al.
Publicado: (2011) -
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC)
por: Casili, Giovanna, et al.
Publicado: (2023)